IATI BOARD CANDIDATES Board Candidates...Bio-Medical group at Xerox PARC. Dr. Wolkin received a PhD in Materials Science, focusing on Nanotechnology and Photonics from the University

IATI BOARDCANDIDATESJune 21, 2015

Erez Tsur | EMC2 | General Manager

Dr. Michal Vakrat Wolkin | 3M | Head of R&D Israel

Oded Meirav | GE Global Research-Israel Technologies Center | Manager

Ra� Margaliot | Senior Vice President | ADM GM, R&D Site GM

Shahar Bar Or | SanDisk | Vice President

Yoav Hochberg | Intel | Vice President Intel Labs, Director Strategic Technologies Group

Yoram Yaacovi | Microsoft Israel R&D Center | General Manager

Yossi Ben-Shoshan | Dell | Director of Dell's Development Center

Alon Aginsky | cVidya | Founder, CEO & President

Avinoam Nowogrodski | Clarizen | Founder & Chief Executive O�cer

Dan Glotter | Optimal+| Founder & CEO

Itzik Frid | Takwin Labs | Partner & CEO

Racheli Ganot | Rachip | Founder, Owner & CEO

Tomer Bar-Zeev | ironSource | Co-founder & CEO

Aaron Mankovski | Pitango | Managing General Partner

Arik Kleinstein | Glilot Capital | Managing Partner

Itzik Parnafes | Battery Ventures | General Partner

Ra� Kesten | JVP | Managing Partner

Yahal Zilka | Magma Venture Partners | Managing Partner

Yoram Oron | Vertex Venture Capital | Founder & General Partner

Guido Pardo-Roques | Philips Electronics | General Manager

Simone Botti | MS Ventures | Head Israel Bioincubator Fund

Yehudah Livneh | Teva | VP Global Public Policy

Multi-National Companies

6 Candidateswill be elected

Technology Companies


VentureCapital Funds


Large lifeScienceCompanies



Anat Cohen Dayag | Compugen | President & CEO

David Malek | BioLineRX | Vice President

David Nitsan | JetPrep | CEO & President

Doron Gal | Kaiima Bio-Agritech | Chief Executive O�cer

Elka Nir | IceCure | Chairman

Gilad Peleg Lorberbaum | BlueWind | Director

Nadav Kidron | Oramed | Chief Executive O�cer & Director

Ruth Ben Yakar | BioSight | CEO

Shirley Giorini Silfen | AF�x Medical | VP Clinical & Regulatory A�airs

Yaky Yanay | Pluristem | President & Chief Operating O�cer

Orli Tori | Bar Ilan Research & Development | CEO

Shlomo Nimrodi | Ramot | CEO

Yaacov Michlin | Yissum | President & CEO

Joey T. Shabot | Greenberg Traurig LLP | Shareholder

Jonathan Eilat | The Investor | Founder & CEO

Omer Ben Zvi | Shibolet & Co | Partner

Yoram Tietz | Ernst & Young | Managing Partner

Yossi Moldawsky | Co-Founder & Chairman | Explore Dream Discover Technological Incubator

Life ScienceCompanies


Technological Incubators

1 Candidatewill be elected

ServiceProviders


Tech Transfer/AcademicInstitutions



Erez Tsur | EMC2 | General Manager

Erez Tsur is currently an IATI board member and Co chairman of the IATI MNC Forum Co leading the Forum which brings together the leaders of the leading Multinational R&D centers in Israel to promote and advance common interests of these centers in Israel. All my professional life I have been supporting hi-tech business and products development.

Today I am the General Manager EMC2 Israel, Computer storage system LTD EMC which is a global leader in enabling businesses and service providers to transform their operations and deliver information technology as a service (ITaaS).

Before end and for 12 years total I served as the General Manager at Cadence design system Israel, a global a leading provider of EDA and semiconductor IP and drove the revolution in semiconductor design and manufacturing of chips that may have billions of transistors that are each far smaller than the wavelength of light used to print them.

Last but not least I am serving on the Board of governs of the MTA - The Academic College of Tel Aviv-Ya�o and a member of its IP/ Patent committee. I am also a member of the business forum of the University of Bar Ilan. I am holding first degree in communicationad computers and a master of business administration with international risk management specialty.


Dr. Michal VakratWolkin is heading 3M's new R&D activities in Israel, with a focus on connecting 3M's global innovations in materials, hardware, and software with the Israeli innovation eco-system.The role includes establishing and leading 3M's innovation center in Israel while collaborating with the Israeli academia, government, multinationals, and startup companies. Her goal is to increase the company's strategic investments in Israel. 3M has been a global leader in Materials innovation for the past 100 years, with over $30 billion in sales, 90,000 employees, and operations in more than 70 countries.

Michal joined 3M in 2014 after living in the USA - Silicon Valley for over 17 years. In her last position Dr. VakratWolkin was the technical Chair of the NASA/Clean Tech Open Night Rover Challenge since

2012. Previously, Michal was Better Place director of Battery technologies in Palo Alto, since the company's early days, until 2012.Before joining Better Place, she was a member of the research sta� at the Palo Alto Research Center (Xerox PARC) Materials and hardware labs working on energy related innivations.Prior to that Dr. VakratWolkin was a Post Doc in the Sensing/ Bio-Medical group at Xerox PARC.

Dr. Wolkin received a PhD in Materials Science, focusing on Nanotechnology and Photonics from the University of Rochester, and an undergraduate degree in Chemical Engineering from The Technion. She holds 10 patent applications, and her research is widely cited. Dr. Vakrat Wolkin currently serves on various industrial review panels related to nanotechnology, batteries, and other electronics areas, she is on advisory boards, and is a frequent speaker at industry events.




Dr. Michal VakratWolkin is heading 3M's new R&D activities in Israel, with a focus on connecting 3M's global innovations in materials, hardware, and software with the Israeli innovation eco-system.The role includes establishing and leading 3M's innovation center in Israel while collaborating with the Israeli academia, government, multinationals, and startup companies. Her goal is to increase the company's strategic investments in Israel. 3M has been a global leader in Materials innovation for the past 100 years, with over $30 billion in sales, 90,000 employees, and operations in more than 70 countries.

Michal joined 3M in 2014 after living in the USA - Silicon Valley for over 17 years. In her last position Dr. VakratWolkin was the technical Chair of the NASA/Clean Tech Open Night Rover Challenge since


2012. Previously, Michal was Better Place director of Battery technologies in Palo Alto, since the company's early days, until 2012.Before joining Better Place, she was a member of the research sta� at the Palo Alto Research Center (Xerox PARC) Materials and hardware labs working on energy related innivations.Prior to that Dr. VakratWolkin was a Post Doc in the Sensing/ Bio-Medical group at Xerox PARC.

Dr. Wolkin received a PhD in Materials Science, focusing on Nanotechnology and Photonics from the University of Rochester, and an undergraduate degree in Chemical Engineering from The Technion. She holds 10 patent applications, and her research is widely cited. Dr. Vakrat Wolkin currently serves on various industrial review panels related to nanotechnology, batteries, and other electronics areas, she is on advisory boards, and is a frequent speaker at industry events.

Oded Meirav | GE Global Research-Israel Technologies Center | Manager

Oded Meirav was born and raised in Israel, Oded attended Hebrew University for his PhD in Physics and completed his postdoctoral work at the TRIUMF lab in Vancouver, Canada. In 2002 Oded earned an MBA from Haifa University.

Oded has been active in the �eld of medical imaging since 1990 and has since held leading positions in CT engineering, clinical applications and marketing in Europe and the US. As the VP of Marketing for UltraGuide in 2000, Oded also managed the US subsidiary. After joining GE Healthcare Israel in 2001, Oded served as a CT project manager and team leader.

In 2007 Oded was elected to launch GE Global Research in Israel.As the GE-GR Business Development Manager, Oded scouted and screened Israeli companies. Serving as the interface between GE and the Israeli Hi-Tech industry, Oded facilitated agreements, collaborations & partnerships between Israeli ventures and various GE entities.

In 2011 Oded was appointed to manage the GE Global Research - Israel Technology Center and its team of technical BD managers. Working in tandem with GE Ventures, the GR-ITC nurtures business relationships at all stages with Israeli companies in the �elds of Energy, Healthcare, Advanced Manufacturing, Robotics, Industrial Internet, and more.



Shahar Bar Or | SanDisk | Vice President

Shahar Bar Or is SanDisk’s Vice President of the Embedded Mobile Engineering where he is responsible for a global engineering organization which executes the research and development of SanDisk’s products for the mobile industry. Shahar is also serving as SanDisk Israel’s Site Manager.Shahar has joined SanDisk from M-Systems, where he has served as VP of RnD for the mobile division. Prior to M-Systems, Shahar held technical leadership positions in IXI mobile and Metalink Broadband.

Ra� Margaliot | HP | Senior Vice President | ADM GM, R&D Site GM

Ra � Margaliot serves as a senior vice president of the Application Delivery Management business unit within HP Software.His team is transforming the delivery of the new style applications by helping customers develop and deliver unbreakable applications running on multiple devices and operating systems that provide mobile users with exceptional and secure user experiences.

Ra� is also leading the HP Software user experience team that drives a consistent modern user experience across the HP Software suite of products. Additionally he is responsible for the HP Software global innovation program, which is dedicated to creating a culture of innovation and harnesses the collective genius of the workforce for the purpose of generating substantial innovations in a systematic, proli-c and robust way.

He previously held a number of GM roles within HP Software, leading both the Enterprise Mobility and IT Management-as-a-Service business units.

Raffi joined HP in 2006 through the acquisition of Mercury Interactive. At Mercury, he held a number of R&D and product management roles and was a founding engineer for what is now the HP Application Lifecycle Management platform. He holds both bachelor’s and master’s degrees in Computer Science from the Hebrew University of Jerusalem.

Ra� is based in Yehud, Israel.




Yoav Hochberg | Intel | Vice President Intel Labs, Director Strategic Technologies Group

Yoav Hochberg is responsible for identifying the trends and developing prototypes for Long Lead Technologies that will shape the computing eco system. Hochberg joined Intel in 1987, serving in numerous business technical and management roles.

2004-2014 Hochberg managed the Strategic planning and Business development in the Intel Architecture Group responsible for the product de�nition of many of Intel’s key projects such as Sandy Bridge, Ivy Bridge, Skylake and the Atom SOC products. In this role Hochberg was also responsible for the identi�cation and startup phase of the Intel Real Sense technology driving technology development, investments and acquisitions in this domain.

2000-2004 Hochberg was the New Business Initiative Manager in Israel and Investment Manager in Intel Capital Israel identifying and investing in internal and external ideas. Hochberg also build and led the Business Development organization in Intel’s Mobile Platform Group and was responsible for driving the program and deals leading to the world wide deployment of Hotspots as part of the Centrino role out.

Previously, in his capacity as Global Design and Design Automation manger from 1997-1999, he was responsible for the development of new design methodologies which greatly improved the productivity and cost performance of mobile CPUs. From 1993 to 1997 Hochberg was the Corporate Design Methodology manager and was thus responsible for the system architecture and design methodology development of the Intel CAD tool suite.He has also held positions as a senior architecture, validation engineer, project manager, and a circuit and logic engineer in data communication and cache controller projects.



Yoram Yaacovi is the general manager of the Microsoft Israel R&D center, responsible for all technology activities in Israel, including the R&D centers in Haifa and Tel Aviv, new core R&D projects, and partnering with the local venture-capital community and academic institutions.

From an industry involvement perspective, Yoram is a board member of the Israeli Advanced Technology Forum (IATI). In 2010 Yoram founded the MNC Forum, a forum that brings together the General Managers of all the Multinational R&D centers in Israel, which consists of close to 50 companies. In addition Yoram is a member of the core team of BTI, and have founded the “Small Steps” workgroup within BTI, to encourage and drive small steps towards co-existence between Israel and Palestine.

Yoram started his career in the previous century (1983) at Elbit Computers where he programmed an innovative real time data entry and display system for the Air Force. In 1984 he joined Intel where he worked for 9 years in engineering, consulting and training roles including working with leading companies in Israel and leading a Unix and X-Windows development team at Intel in Santa Clara. In 1993 Yoram joined Microsoft in Redmond where he spent 11 years in software development and development management roles building products and technologies such as Windows 95, NetMeeting, the Microsoft Reader, ClearType, MSN Communities, and the Microsoft Rights Management (DRM) Server. In his last job in Redmond, Yoram was Group Manager in the Information Worker division responsible for the incubation of the O�ce Information Bridge Framework.

Between 2004 and 2008 Yoram was a Vice President at Amdocs (NYSE:DOX) - a leading telecom software provider, where he led the development of the Amdocs product portfolio as the head of the Amdocs Product Development Organization and later as the COO of the Amdocs Products Group.

In 2008 Yoram returned to Microsoft to act as CTO of the Microsoft Israel Development Center (ILDC) and General Manager for technologies at ILDC. His responsibilities included the ILDC innovation labs - a green-house for breakthrough developments, new technologies and business groups, academia and industry outreach and programs and the technology connection with the Microsoft corporate headquarters.

Yoram is the co-author of 23 patent applications (7 approved so far) and several IETF RFCs. He has a BSc in Computer Science from the Technion.





Yoram Yaacovi is the general manager of the Microsoft Israel R&D center, responsible for all technology activities in Israel, including the R&D centers in Haifa and Tel Aviv, new core R&D projects, and partnering with the local venture-capital community and academic institutions.

From an industry involvement perspective, Yoram is a board member of the Israeli Advanced Technology Forum (IATI). In 2010 Yoram founded the MNC Forum, a forum that brings together the General Managers of all the Multinational R&D centers in Israel, which consists of close to 50 companies. In addition Yoram is a member of the core team of BTI, and have founded the “Small Steps” workgroup within BTI, to encourage and drive small steps towards co-existence between Israel and Palestine.

Yoram started his career in the previous century (1983) at Elbit Computers where he programmed an innovative real time data entry and display system for the Air Force. In 1984 he joined Intel where he worked for 9 years in engineering, consulting and training roles including working with leading companies in Israel and leading a Unix and X-Windows development team at Intel in Santa Clara. In 1993 Yoram joined Microsoft in Redmond where he spent 11 years in software development and development management roles building products and technologies such as Windows 95, NetMeeting, the Microsoft Reader, ClearType, MSN Communities, and the Microsoft Rights Management (DRM) Server. In his last job in Redmond, Yoram was Group Manager in the Information Worker division responsible for the incubation of the O�ce Information Bridge Framework.

Between 2004 and 2008 Yoram was a Vice President at Amdocs (NYSE:DOX) - a leading telecom software provider, where he led the development of the Amdocs product portfolio as the head of the Amdocs Product Development Organization and later as the COO of the Amdocs Products Group.

In 2008 Yoram returned to Microsoft to act as CTO of the Microsoft Israel Development Center (ILDC) and General Manager for technologies at ILDC. His responsibilities included the ILDC innovation labs - a green-house for breakthrough developments, new technologies and business groups, academia and industry outreach and programs and the technology connection with the Microsoft corporate headquarters.

Yoram is the co-author of 23 patent applications (7 approved so far) and several IETF RFCs. He has a BSc in Computer Science from the Technion.



Alon Aginsky | cVidya | Founder, CEO & President

Alon Aginsky assumed the lead role at cVidya Networks withover 20 years of management and marketing experience in the telecommunications, software development and network management industries.

Prior to cVidya, Mr. Aginsky served as Vice President of Business Development and Business Alliances at C. Mer Industries, where he was responsible for new ventures in telco customer care, billing, and network-management solutions. He was also Vice President of Sales and Marketing at MerTelemanagement Solutions (NASDAQ: MTSL), where he was responsible for the company’s global marketing and sales e�orts. In this capacity, Mr. Aginsky successfully led the public o�ering of MTS on NASDAQ.






Yossi Ben-Shoshan | Dell | Director of Dell's Development Center

Yossi Ben-Shoshan serves as a Director in Dell’s data storage division and as the director of Dell's development center in Israel. The Dell Israeli development center focuses on developing �le systems and NAS solutions.

Before Dell, Yossi worked for Exanet, a company which specialized in the development of distributed data storage solutions, the company was later acquired by Dell. At Exanet, Yossi led product management and technology from the initial steps to distributing the product in Europe and in North America.

Before Exanet Yossi managed R&D for Leaf Systems, a US based company engaged in the development of digital cameras for commercial applications. Leaf was a wholly owned subsidiary of Scitex Inc.

Prior to that, Yossi managed the development of various software products at the American branch of Scitex.

Yossi holds a BSEE from Tel Aviv University.

Avinoam Nowogrodski | Clarizen | Founder & Chief Executive O�cer

Avinoam Nowogrodski brings over 20 years of experience in sales, engineering and business management to Clarizen. He brings insight and expertise gained in those positions to Clarizen's vision of bringing collaborative project management to every business.

Prior to establishing Clarizen, Avinoam co-founded SmarTeam Corporation, a leading provider of collaborative product life cycle management (PLM) solutions. As CEO from 1995 – 2005, Avinoam's leadership molded SmarTeam into a leading enterprise PLM solution which was sold and supported by IBM. In 1999 SmarTeam was acquired by DassaultSystemes (DS) and Avinoam served on the DS General Executive Management team for 6 years. At his departure from the company, SmarTeam had 3,500 customers across diverse industries and over 100,000 users worldwide.

Avinoam Nowogrodski holds a BSc in Electrical Engineering fromTel Aviv University, Israel.


Dan Glotter | Optimal+ | Founder & CEO

Dan Glotter is the Founder & CEO of Optimal+, a startup company with over 150 employees. Dan has been an IATI board member for the last 2 years and represent the spirit, motivations and interests of the start-ups in Israel.

Dan brings vast experience of both the start-up world and multinational corporate world, as he was part of the leading Intel team that established the Intel factory in Kiryat Gat from “green-�eld” to maturity (1994-2004). In all his years at Intel he was part of the top management team including the Manufacturing manager and the Test manager.

Prior he was the CEO of Playscape (MoMinis); Managing Director of Argoquest (and VP Business A�airs of one of his portfolio companies, InfoGin); VP Business A�airs at AOL and Senior Advisor to the Minister of Finance. Itzik has been a Board member of IATI since 2012 and is an investor and board member of several startup companies. he graduated Physics before his army service and Law after, both from the Tel Aviv university.


Itzik Frid is the Managing Partner and CEO of Takwin Labs, a return driven fund and incubator, which makes seed investments in hi-tech ventures founded by Arab entrepreneurs. Takwin was founded by Chemi Peres (Pitango), Erel Margalit (JVP) and Imad Telhami.



Prior he was the CEO of Playscape (MoMinis); Managing Director of Argoquest (and VP Business A�airs of one of his portfolio companies, InfoGin); VP Business A�airs at AOL and Senior Advisor to the Minister of Finance. Itzik has been a Board member of IATI since 2012 and is an investor and board member of several startup companies. he graduated Physics before his army service and Law after, both from the Tel Aviv university.



Itzik Frid is the Managing Partner and CEO of Takwin Labs, a return driven fund and incubator, which makes seed investments in hi-tech ventures founded by Arab entrepreneurs. Takwin was founded by Chemi Peres (Pitango), Erel Margalit (JVP) and Imad Telhami.

Tomer Bar-Zeev | ironSource | Co-founder & CEO

Tomer Bar-Zeev is the Co-founder and CEO of ironSource, a world leading digital distribution company. He was also the Co-founder and CEO of FoxTab, a popular 3D tab management Firefox browser add-on, which joined the ironSource family of companies in 2011. Previously, he served in VP positions at Payoneer and Atlas CT.

Racheli Ganot | Rachip | Founder, Owner & CEO

Racheli Ganot, (38, mother of three) Founder, Owner and CEO (since 2007) of the high-tech company Rachip ltd, which employs about 100 Ultra Orthodox (Haredi) engineers, in developing SW, chips and systems. Rachip has two R&D centers in BneiBrak and Haifa. Among the Company's clients included MNCs like: Intel, Freescale, Nuvoton, Qualcomm, Mellanox and more, Israeli defense companies like IAI and Elbit and start-ups like RamonChips and PLSense.

Member at the board of Directors of the startup company i-Sale.Co-Founder and Chairman of Ultra-Orthodox (Haredi) Hightech Forum, non-pro�t organization which promotes and encourages Haredi Hightech entrepreneurship, launched the �rst HarediIncubator in Bnei-Brak. Board member of non-pro�t organization "Panim-Hadashot", which promotes and encourages high-school girls to chose science and technology studies.In 2013 Racheli was chosen as one of 50 most in�uential women by the Lady Globes Magazine.

Racheli has BSc in Computer Science from Bar-Ilan University,International EMBA student in Kellogg-Recanati business school




Aaron Mankovski | Pitango | Managing General Partner

Aaron Mankovski is a Managing General Partner at Pitango Venture Capital. Previously he founded, and was a Managing General Partner, of Eucalyptus Ventures. Prior to founding Eucalyptus, he served as Corporate Vice President of Orbotech Ltd.(NASDAQ: ORBK).In addition, Aaron served as President and CEO of Orbotech Inc., HQ in Boston USA.

Aaron currently serves on the boards of: OptimalPlus, Kilopass Technology Inc., Compass-EOS, Kaminario and observer at Formlabs. Previously he served on the Board of Directors of Chromatis Networks (acquired by Lucent for $4.5 Billion).

Arik Kleinstein | Glilot Capital | Managing Partner

Arik Kleinstein is the Co-Founder and Managing Partner of Glilot Capital, a venture capital fund founded in 2011.Glilot is focused on seed stage software companies, invested in 8 companies and distributed signi�cant pro�ts to its investors in less than 4 years since its inception. Glilot’s portfolio companies included Aorato (acquitted by Microsoft), Insightera (acquired by Marketo) and Porticor (acquired by Intuit). Glilot recently closed its 2nd fund that has $77M under management.

Before Founding Glilot Arik lived 9 years in the US working as an executive for ECTel (acquired by Verint), VideoCodes (acquired by Thompson) and Intercure (IPO). Before relocating to the US, Arik was for 5 years with Jerusalem-Global, an Israeli VC fund. Arik Holds Degrees in Industrial Engineering and Management (Technion) and MBA (Tel Aviv) and served as an Engineer in Unit 8200.


Itzik Parnafes focuses on investments in information technology.He is currently on the boards of 90min, SiSense, Elasti�le, Plexistore, Datumate, GoEuro, LightCyber and Primary Data. He is a board observer in Scodix and ZeRTO and led Battery’s investment in Delphix. Itzik was on the board of XtremIO (acquired by EMC), Cyvera (acquired by Palo Alto Networks) and Panaya (acquired by Infosys).

Before Battery, Itzik was a partner with Stata Ventures, where he led investments in Provigent (acq: Broadcom), Comability (acq: Ruckus Wireless), Sentrigo (acq: Symantec). Itzik is a 8200 alumni and is on the board of the 8200 EISP Accelerator program, and he likes sailing, skiing and lamenting his poor Tennis skills.




Itzik Parnafes focuses on investments in information technology.He is currently on the boards of 90min, SiSense, Elasti�le, Plexistore, Datumate, GoEuro, LightCyber and Primary Data. He is a board observer in Scodix and ZeRTO and led Battery’s investment in Delphix. Itzik was on the board of XtremIO (acquired by EMC), Cyvera (acquired by Palo Alto Networks) and Panaya (acquired by Infosys).


Before Battery, Itzik was a partner with Stata Ventures, where he led investments in Provigent (acq: Broadcom), Comability (acq: Ruckus Wireless), Sentrigo (acq: Symantec). Itzik is a 8200 alumni and is on the board of the 8200 EISP Accelerator program, and he likes sailing, skiing and lamenting his poor Tennis skills.

Ra� Kesten | JVP | Managing Partner

A seasoned veteran of the global business scene, Ra� brings to JVP over 20 years of experience in semiconductors and new materials, as well as a deep business and operational understanding of the media and security worlds. Having served as a Venture Partner at JVP over the past decade, Ra� took over the role as Managing Partner. Ra� also serves as special advisor to Cisco Systems’ CEO Mr. John Chambers on all matters of video technologies. Ra� serves on the board of JVP's portfolio companies CyberArk Software (NASDAQ: CYBR) and Siano Mobile. Ra� was instrumental in leading the sale of JVP’s portfolio company EPOS to Qualcomm in 2012.

Widely considered an expert in his �eld, Ra� was until recently Vice President of Service Provider Video Security, Software & Solutions Group at Cisco Systems previously holding the position of General Manager of NDS Israel and as Senior Vice President of NDS World Wide prior to its acquisition in 2012 by Cisco. Ahead of joining NDS, Ra� was VP of Operations and Production of Imaging Products at printing innovator Indigo, subsequently sold to HP.

At Indigo, he was responsible for production output of sophisticated Imaging products, logistics, budget control and interaction with key customers. Previously, Ra� worked at Intel, where he held several engineering and managerial positions, including process engineering, integration of advanced technologies, deployment of state of the art equipment and human resources managerial activities.

During his 11 years at Intel, Ra� won numerous awards for his forward thinking and problem solving. Among these awards is the international achievement award for the development of an improved process that doubled the yield of the 80386 chip.

Ra� served in an elite commando unit of the Israeli Defense Forces.




Yahal Zilka | Magma Venture Partners | Managing Partner

For the past �fteen years, Yahal Zilka served as co-Founder and Managing Partner of Magma Venture Partners, a leading early-stage Venture Capital Fund focused on Israeli related Information, Communication, and Technology (ICT) space.

Mr. Zilka contributed to the positioning of Magma as a major player in the New Media space. Yahal led the �rst investment at Waze (acquired by Google), and Magma’s �rst exit with Phonetic Systems where he was Chairman and acting CEO. In addition, he served on the Board of Directors of Onavo (acquired by Facebook), DesignArt (acquired by Qualcomm) and Adience (acquired). He currently is on the Board of Valens semiconductors and Magisto among others.

Prior to Magma, Yahal served as CFO of VocalTec Communications from 1995 to 1999, where he was part of the team that pioneered VOIP. He led the company to its public o�ering on NASDAQ (Nasdaq: VOCLF), and developed important strategic relations with vendors and carriers including VocalTec’s noteworthy deal with Deutsche Telekom that ultimately led to the global recognition and adoption of VOIP.

Yahal brings strong hands-on management and entrepreneurial experience in all lifecycle stages of communications ventures, as well as strong knowledge and relationships with leading technology and software vendors.

Yahal has been a strong activist at the IATI and its predecessor organization, Chaired for three consecutive years the Conference Committee and prior to that the Social Activity Committee. In the past two years, he was supportive of the Chairman and CEO on numerous initiatives related to advancing the organization.


Yoram Oron founded Vertex Venture Capital in 1997 as part of the Yozma Program together with Vertex Venture Holdings. Vertex VC Israel invested in Morecom (sold to Liberate), Tradeum (sold to VerticalNet), Vision Tech (sold to Broadcom), Actimize (Sold to NICE), dbMotion (sold to Allscript), Waze (sold to Google) and CyberArk (IPO in Nasdaq).

Prior to founding Vertex Israel, Yoram was Chairman of Telegate from its inception in 1993 until its acquisition by Terayon in 1999.Previously, Yoram was President and CEO of Aryt Industries, and Co-Founder and CEO of Reshef Technologies.Yoram graduated with an M.B.A. from Tel Aviv University, Israel and a B.Sc. in Electrical Engineering from the Technion - Israel Institute of Technology.




Yoram Oron founded Vertex Venture Capital in 1997 as part of the Yozma Program together with Vertex Venture Holdings. Vertex VC Israel invested in Morecom (sold to Liberate), Tradeum (sold to VerticalNet), Vision Tech (sold to Broadcom), Actimize (Sold to NICE), dbMotion (sold to Allscript), Waze (sold to Google) and CyberArk (IPO in Nasdaq).


Prior to founding Vertex Israel, Yoram was Chairman of Telegate from its inception in 1993 until its acquisition by Terayon in 1999.Previously, Yoram was President and CEO of Aryt Industries, and Co-Founder and CEO of Reshef Technologies.Yoram graduated with an M.B.A. from Tel Aviv University, Israel and a B.Sc. in Electrical Engineering from the Technion - Israel Institute of Technology.

Guido Pardo-Roques | Philips Electronics | General Manager

Guido Pardo-Roques is the President and CEO of Philips Electronics (Israel) and General Manager of Philips Medical Systems Technologies LTD (PMSTL) with sites in MATAM Haifa, PetachTikva and Raanana, Israel; PMSTL is the �agship of Philips interests in Israel with more than 800 R&D and manufacturing employees dedicated to Healthcare innovation in the �elds of Diagnostic Imaging (CT and PET), Multimodality Software Clinical Applications (CT, PET, MRI, interventional X-RAY, Ultrasound, etc), Healthcare IT. In 2014, Philips Israel opened an innovation branch, Sanara Ventures, (in partnership with Teva) that includes a Healthcare Technological Incubator under the auspices of the Chief Scientist.

Guido joined Elscint’s CT Division in 1980; in 1988 he was appointed to Project Manager of the CT Twin, the world’s �rst multislice scanner, a breakthrough product that changed forever the CT imaging landscape. In 1993, Guido was appointed to R&D Manager of Elscint CT and in this function was key in the acquisitions by Picker (1998) and Philips (2001).

Guido holds BSc and MSc from the Technion in Haifa, and MBA from the Haifa University. In 1997, for the success of the CT Twin, Guido, received the Rotschild Prize for Innovation.


Leads MS Ventures, the Corporate Venture Capital arm of Merck Serono, in Israel, since 2011. In this position, Simone was responsible for the establishment of the MS Ventures Israel Bioincubator, aa strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. The MS Ventures Israel Bioincubator is the only private

incubator of its kind in Israel, and since 2012 has been one of the most active investors in seed and early stage life science technologies in Israel. As part of his activities, Simone acts as interim CEO of the Incubator portfolio companies, which has given him an in depth knowledge of the needs of early stage Israeli life science companies in their daily struggle to grow and compete on the global stage for funding a partnerships. Before joining MS Ventures, Simone was Vice President, Business Development at RAD Biomed Accelerator, one of Israel’s leading Life science incubators; before RAD Biomed, he was Senior Director, Business Development at Cogenics.

Simone has been also a Board Member of IATI, the Israel Advanced Technology Industries association for the past three years.Simone holds a PhD in Chemistry from the Weizmann Institute of Science, where he received the “Dov Elad” prize in Structural Biology and was NIH–ADDP Fellow at Northwestern University Medical School in Chicago






Leads MS Ventures, the Corporate Venture Capital arm of Merck Serono, in Israel, since 2011. In this position, Simone was responsible for the establishment of the MS Ventures Israel Bioincubator, aa strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. The MS Ventures Israel Bioincubator is the only private


incubator of its kind in Israel, and since 2012 has been one of the most active investors in seed and early stage life science technologies in Israel. As part of his activities, Simone acts as interim CEO of the Incubator portfolio companies, which has given him an in depth knowledge of the needs of early stage Israeli life science companies in their daily struggle to grow and compete on the global stage for funding a partnerships. Before joining MS Ventures, Simone was Vice President, Business Development at RAD Biomed Accelerator, one of Israel’s leading Life science incubators; before RAD Biomed, he was Senior Director, Business Development at Cogenics.

Simone has been also a Board Member of IATI, the Israel Advanced Technology Industries association for the past three years.Simone holds a PhD in Chemistry from the Weizmann Institute of Science, where he received the “Dov Elad” prize in Structural Biology and was NIH–ADDP Fellow at Northwestern University Medical School in Chicago

Yehudah Livneh | Teva | VP Global Public Policy

VP Global Public Policy December 2012 – PresentEstablished and co-chaired Global Public Policy group responsible for identifying global policy issues, engaging senior executives and establishing global public policy. Policies included Incentives for Innovation, Clinical Data Transparency and Anti-counterfeiting policies.

Education and Degrees:1981 Ph.D. Molecular Biology - Biochemistry,Brandeis University, USA1975 B.Sc. Honors, Chemistry, Hebrew University, Jerusalem, Israel




Anat Cohen Dayag | Compugen | President & CEO

Dr. Cohen-Dayag joined Compugen in 2002, and has held the positions of Director of Diagnostics, VP Diagnostic Biomarkers & Drug Targets and VP R&D. In 2009, Dr. Cohen-Dayag was appointed, together with Mr. Martin Gerstel, as co-CEO of Compugen. In 2010, Dr. Cohen-Dayag was appointed Compugen President and CEO. Prior to joining Compugen, she was head of R&D and a member of the executive management at MindsenseBiosystems.

Dr. Cohen-Dayag holds a B.S. in Biology from Ben-Gurion University, and an M.S. in chemical immunology and a Ph.D. in cellular biology from the Weizmann Institute of Science. In addition, Dr. Cohen-Dayag is a director of Ramot at Tel Aviv University Ltd.,and a director of the IATI (Israeli Advanced Technologies Industries).


David Malek holds the position of Vice President, Business Development, at BioLineRx, since 2011.BioLineRx is a unique company playing an important role in the Israeli life sciences industry and I was fortunate to take part of that: as part of my job, I am responsible for both the scouting & in-licensing activities at BioLineRx, as well as for the out-licensing activities.My in-licensing activities bring me to interact on a regular basis with many of the key stakeholders in the local biotech community: BioLineRx has traditionally held a large and diverse pipeline, comprised primarily of Israeli-based innovation, and thus I am exposed regularly to the innovations coming from Israel, and in parallel also have a good view on how that compares to other countries where we have scouted for projects. As far as the out- licensing is concerned, a large part of my role is to collaborate and partner with global partners on our innovation, and therefore I have a good view on their preferences and concerns. Over the last 3 years we have been able to establish partnerships with academia, small biotech, large pharmaceutical companies, small pharmaceutical companies and services providers. These partnerships happened with Israeli parties, but also with parties in the US, Europe and China.

Before joining BioLineRx I worked for Sano�-Aventis for 5 years in a

variety of roles with increasing responsibilities. I headed marketing for cardiovascular and oncology drugs in the US for several years, and gained signi�cant experience working in BD functions in the US and in the global headquarters. This has provided me with the SimoneBotti is wide perspective of a large pharma company, and allowed me to see how di�erent small companies in di�erent regions develop and commercialize their projects.

Prior to joining Sano�-Aventis served as Major at the Israeli Air Force. Received his MBA from the Tuck School of Business at Dartmouth and B.A. in statistics and political science from the University of Haifa.

As a potential member of the Board at IATI I am excited to identify with the team two or three key challenges which the majority of the industry in Israel faces, and combine the e�orts of the di�erent parties to construct productive solutions which would hopefully solve some of the structural challenges limiting our industry from growing. I would also be happy to try and help bridge the gap between smaller local companies and large global �rms, having seen the world from both angles.




David Malek holds the position of Vice President, Business Development, at BioLineRx, since 2011.BioLineRx is a unique company playing an important role in the Israeli life sciences industry and I was fortunate to take part of that: as part of my job, I am responsible for both the scouting & in-licensing activities at BioLineRx, as well as for the out-licensing activities.My in-licensing activities bring me to interact on a regular basis with many of the key stakeholders in the local biotech community: BioLineRx has traditionally held a large and diverse pipeline, comprised primarily of Israeli-based innovation, and thus I am exposed regularly to the innovations coming from Israel, and in parallel also have a good view on how that compares to other countries where we have scouted for projects. As far as the out- licensing is concerned, a large part of my role is to collaborate and partner with global partners on our innovation, and therefore I have a good view on their preferences and concerns. Over the last 3 years we have been able to establish partnerships with academia, small biotech, large pharmaceutical companies, small pharmaceutical companies and services providers. These partnerships happened with Israeli parties, but also with parties in the US, Europe and China.

Before joining BioLineRx I worked for Sano�-Aventis for 5 years in a


variety of roles with increasing responsibilities. I headed marketing for cardiovascular and oncology drugs in the US for several years, and gained signi�cant experience working in BD functions in the US and in the global headquarters. This has provided me with the SimoneBotti is wide perspective of a large pharma company, and allowed me to see how di�erent small companies in di�erent regions develop and commercialize their projects.

Prior to joining Sano�-Aventis served as Major at the Israeli Air Force. Received his MBA from the Tuck School of Business at Dartmouth and B.A. in statistics and political science from the University of Haifa.

As a potential member of the Board at IATI I am excited to identify with the team two or three key challenges which the majority of the industry in Israel faces, and combine the e�orts of the di�erent parties to construct productive solutions which would hopefully solve some of the structural challenges limiting our industry from growing. I would also be happy to try and help bridge the gap between smaller local companies and large global �rms, having seen the world from both angles.

David Nitsan | JetPrep | CEO & President

Dan Nitsan has been the CEO & President of JetPrep ltd for the past 8 years. I have entrepreneurial experience and senior management of 15 years in the Israeli Start-up environment in many positions of which over 7 years as CEO JetPrep Ltd. I brought the company from early stage to commercialization in EU and USA. Also, successfully reached an M&A (exit) with a strategic partner, Cantel Medical Inc. (NYSE: CMN). Following the M&A transaction (2013), I am also serving as the Vice President of Global New Business Development for Medi-vatorsInc (A Cantel Medical Company).

I have deep experience in both domestic and international markets (Asia, US, Europe) with extensive experience in all technical, management and corporate matters.

I hold a B.Sc degree in Mechanical Engineering and a M.Sc Degree in Biomedical Engineering both from the Tel-Aviv University.In addition, I have an Executive MBA from Tel-Aviv University.




Doron Gal | Kaiima Bio-Agritech | Chief Executive O�cer

Dr. Doron Gal is the Chief Executive O�cer of Kaiima Bio-Agritech, which he co-founded in 2007. Kaiima has developed a novel technology platform that promises to deliver unprecedented enhancement of productivity to the world's most important food and energy crops. Doron led three highly successful rounds of funding for Kaiima totaling more than $100M from world leading investors such as the IFC (World Bank), Kleiner Perkins Caul�eld and Byers, Draper Fisher Jurvetson and Horizons Ventures. Kaiima now numbers more than 100 employees in its home campus and overseas subsidiaries and has partnered with the world's most important seed companies to deliver its technology to farmers around the globe. It has won numerous prestigious industry awards and was named as one of the 50 Smartest Companies by MIT Technology Review.

Prior to Kaiima, Dr. Gal ran a private Energy Trends and Technologies consultancy for commercial organizations and government agencies. Doron also served as an Adj. Lecturer on Energy and Geo-strategy at the Lauder School of Government, IDC Herzliya and a Senior Research Fellow (Energy) for the Institute for Policy and Strategy. Recently, Dr. Gal was also appointed to Chair the Board of Directors of Pimi Agro Cleantech, a company that develops eco-friendly solutions to address the problem of post-harvest loss and promote sustainable food security.

He holds a Ph.D. in Geophysics from Stanford University.

Mrs. Nir is a board director of the Israeli High Tech Association (IATI), contributed to its various committees. The unique combination of experience in leading large and small companies, operationally and as a board member, together withvast experience as a VC partner and investor, working closely with incubators and managing a university TTO provides Elka a very wide point of view and in depth understanding of the Israeli high tech and Life Sciences arena Formerly, Elka has been Managing Director, Life Sciences in Giza Venture Capital. Elka also served as COO & Director at Biosense Webster, Johnson & Johnson and VP, R&D and VP Marketing at GE Healthcare, Israel.




Elka Nir has more than 25 years of extensive experience in senior executive positions in the area of Life Sciences. She brings signi�cant experience in various executive leadership roles in large and small global companies as well as in Venture Capital. Mrs. Nir has in depth knowledge of the Israeli hi-tech / life sciences arena including strong network with startups, incubators, local and global investors, and strategic players. Elka is an active chairperson and board member of several public and private Life Sciences companies in various stages, including :IceCure, BSP, BATM, EyeYon, Cologuard, Laryngoport and others. Elka is also the CEO of the Economic Corporation of theHaifa University.


Mrs. Nir is a board director of the Israeli High Tech Association (IATI), contributed to its various committees. The unique combination of experience in leading large and small companies, operationally and as a board member, together withvast experience as a VC partner and investor, working closely with incubators and managing a university TTO provides Elka a very wide point of view and in depth understanding of the Israeli high tech and Life Sciences arena Formerly, Elka has been Managing Director, Life Sciences in Giza Venture Capital. Elka also served as COO & Director at Biosense Webster, Johnson & Johnson and VP, R&D and VP Marketing at GE Healthcare, Israel.

Nadav Kidron | Oramed | Chief Executive O�cer & Director

Nadav Kidron serves as Chief Executive O�cer & Director of Oramed Pharmaceuticals, which he co-founded in 2006.Mr. Kidron is an entrepreneur whose experience includes senior executive roles in a wide range of industries.

He is a member on the Board of Directors of Entera Bio, which started as a joint venture formed by Oramed and DNA Biomedical Solutions; and an international lecturer on Israel’s entrepreneurial culture and the country’s roots as an oasis of innovative ideas.

He holds a bachelors degree in law and an international masters in business administration, both from Bar-Ilan University in Israel. Mr. Kidron is a fellow of the Merage Business Executive Leadership Program and a member of the Israeli Bar Association.



Gilad Peleg Lorberbaum | BlueWind | Director

A seasoned life sciences executive with a broad and diverse experience base, which includes blue chip corporate business development, the launching of innovative start-ups, and venture capital/private equity portfolio management.

Currently Board member at Bluewind Medical, and Slender Medical, and C.O.O. at Rainbow Medical Ltd. (RMD), were Gilad is part of the management team at an operational investment company that has incorporated and invested in 12 portfolio companies and developed over 25 pipeline projects.


Elka Nir has more than 25 years of extensive experience in senior executive positions in the area of Life Sciences. She brings signi�cant experience in various executive leadership roles in large and small global companies as well as in Venture Capital. Mrs. Nir has in depth knowledge of the Israeli hi-tech / life sciences arena including strong network with startups, incubators, local and global investors, and strategic players. Elka is an active chairperson and board member of several public and private Life Sciences companies in various stages, including :IceCure, BSP, BATM, EyeYon, Cologuard, Laryngoport and others. Elka is also the CEO of the Economic Corporation of theHaifa University.


Ruth Ben Yakar | BioSight | CEO

Dr. BenYakar has over 22 years of experience in the biomedical �eld, including over 14 years of management in the biotech industry, leading diverse corporate, business, operational, �nancial, clinical development, and research activities.

Dr. Ben Yakar currently serves as the CEO of BioSight, as well as a Director at SHL Telemedicine, Cellect Biotechnology, and IATI Board of Directors, as well as a professional consultant to several biomed companies. She also serves as a lecturer at Lahav, the Recannati Business School of Tel-Aviv University, presenting the Israeli biomed industry to investors and business groups.Dr. Ben Yakar formerly served as the CEO of Procognia, a biotech company traded on the TASE, where she established the company as a leader in biopharma-ceutical analytics. Prior to that, Dr. Ben Yakar was the CEO of Throm-botech, where she led a multi-center phase II clinical trial and led the company towards acquisition. Prior to that, Dr. Ben Yakar served as the Chief Business O�cer of YEDA, the technology transfer company of the Weizmann Institute of Science, responsible for the commercial-ization of the WIS technologies, and a Vice President in several Biotech companies where she led diverse product development activities and clinical and pre-clinical R&D projects.

Dr. Ben Yakar holds a Ph.D. Cum Laude in molecular biology from the Weizmann Institute of Science. Her research, in the �eld of oncology, yielded several prestigious publications and awards.

Shirley Giorini Silfen | AF�x Medical | VP Clinical & Regulatory A�airs

Shirley Giorini has over 15 years of extensive experience in the medical device industry including holding senior roles at Gardia Medical, Kendle International, BioControl Medical and Medtronic Instent. Professional experience includes strategic clinical, regulatory, scienti�c and commercialization planning as early as the product conception, design of pre clinical and clinical studies accordingto international standards and guidelines, as well as SOPs development, that assist companies in developing the safety and e�cacy data needed to obtaining a market approval. In addition the conduct of market research surveys for current and future products applications and involvement in all kind of medical writing.




Yaky Yanay | Pluristem | President & Chief Operating O�cer

Yaky Yanay was appointed as Pluristem’s President and Chief Operating O�cer in February 2014. Until February 2014, he served as Pluristem’s Chief Financial O�cer and Secretary since November 2006, and Executive Vice President since March 2013.

Prior to joining Pluristem, Mr. Yanay was the Chief Financial O�cer of Elbit Vision Systems Ltd., a public company. Prior to that Mr. Yanay served as manager of audit groups of the technology sector at Ernst & Young Israel. Mr. Yanay founded and served as Chairman of the “The Life Science Forum” and is a member of the board of directors of Israel Advanced Technologies Industries (IATI), the largest umbrella organization in Israel for companies, organizations, and individuals in the high tech and life science sectors.

Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting and is a Certi�ed Public Accountant in Israel.

Orli Tori | Bar Ilan Research & Development | CEO

Orli Tori came to Bar Ilan Research & Development after serving in various executive roles in the pharmaceutical industry. In her last position as General Manager of Neopharm, a diversi�ed company combining activity in pharmaceuticals, medical and scienti�c devices, diagnostics, consumer health care products and home therapy services, Tori was responsible for overall strategic direction and managed annual revenues of 770 million NIS. Orli serves at the board of directors of biotechnology companies and co-chair the Israeli Technology Transfer Organization.Tori holds a Master degree in microbiology (cum laude) from Tel Aviv University, where she also did her undergraduate work. She has completed economics and marketing courses for Senior Executives at Tel Aviv University the Ben-Gurion University and Wharton University.


Shlomo Nimrodi is the CEO of Ramot at Tel Aviv University since June 2012, Mr. Shlomo Nimrodi brings with him more than 25 years track record leading technology companies, in wide range of industries,

locally and internationally, turning them into pro�table businesses, creating expanded markets for technological innovations. Through a series of innovative programs, Shlomo has positioned Ramot at the forefront of the Tech Transfer organizations around the world. Among such programs included, the formation of the Technology Innovation Momentum Fund, a $25 million investment fund for early stage Promising Innovations from Tel Aviv University, with Tata and Temasek, two world leading organizations, as lead investors and the formation of the Center of Innovation and Entrepreneurship at Tel Aviv University.

Among the companies Shlomo has led are: Epana Networks – a $200+ million revenue communications and �nancial services company; Raytel Cardiac Services - a leading company in the �eld of remote monitoring of cardiac services that was acquired by Philips; Nexus Data - a leading company in the AMR �eld that was acquired by Sensus Metering Systems; Vizrt – a publicly traded world leading company in broadcast graphics that was recently acquired by a major Nordic private equity, and Indigo, as the CFO and COO, the market leader in digital printing technology that was acquired by HP in early 2000.

Mr. Nimrodi graduated with an MA and MBA with Honors in 1983 from the Hebrew University of Jerusalem and completed the Advanced Management Program (AMP156) in 1999 at Harvard Business School.






Shlomo Nimrodi is the CEO of Ramot at Tel Aviv University since June 2012, Mr. Shlomo Nimrodi brings with him more than 25 years track record leading technology companies, in wide range of industries,


locally and internationally, turning them into pro�table businesses, creating expanded markets for technological innovations. Through a series of innovative programs, Shlomo has positioned Ramot at the forefront of the Tech Transfer organizations around the world. Among such programs included, the formation of the Technology Innovation Momentum Fund, a $25 million investment fund for early stage Promising Innovations from Tel Aviv University, with Tata and Temasek, two world leading organizations, as lead investors and the formation of the Center of Innovation and Entrepreneurship at Tel Aviv University.

Among the companies Shlomo has led are: Epana Networks – a $200+ million revenue communications and �nancial services company; Raytel Cardiac Services - a leading company in the �eld of remote monitoring of cardiac services that was acquired by Philips; Nexus Data - a leading company in the AMR �eld that was acquired by Sensus Metering Systems; Vizrt – a publicly traded world leading company in broadcast graphics that was recently acquired by a major Nordic private equity, and Indigo, as the CFO and COO, the market leader in digital printing technology that was acquired by HP in early 2000.

Mr. Nimrodi graduated with an MA and MBA with Honors in 1983 from the Hebrew University of Jerusalem and completed the Advanced Management Program (AMP156) in 1999 at Harvard Business School.


Yaacov Michlin serves as Yissum's President and Chief Executive O�cer since 2009. Michlin has been leading more than 300 licensing deals and the creation of more than 40 start up companies. Recnetly, Michlin led the creation and capital raising of Yissum's new holding company in the biotech area -Integra that acts as VC to fund biotech projects of HU and Agrinnovation that funds and invests in start up in the Agritech area. Michlin serves as chairman of Integra and Agrin-novation who manage $20 million investments. Michlin also led Yissum to the signing of long term collaborations with Roche, P&G , Coca Cola and other multinational companies. Michlin currently serves as chairman of Qlight Nanotech (in strategic collaboration with Merck) and Avraham Pharma (PIIb MCI Product) and as board member of few of Yissum leading spin-o� companies in the biotech,

agriculture and other �elds. In May 2015 Michlin resigned from his role as co-chairman of the Israeli Tech Transfer Organization after 3 years in which he managed to increase substantially the activities and marketing of the ITTN. Before joining Yissum, Yaacov was involved in consulting to pharmaceutical, hi-tech and biomedical companies (including Teva, Bioline, CBI and Brainsway) in various technology commercialization deals, licensing agreements, capital raising, mergers and acquisitions and joint venture collaborations. Michlin holds a Bachelor of Law and Economics, cum laude, and a Master of Law degree, both from Bar-Ilan University, Israel, and a MBA, cum laude, from the Technion Israel Institute of technology.




Yaacov Michlin serves as Yissum's President and Chief Executive O�cer since 2009. Michlin has been leading more than 300 licensing deals and the creation of more than 40 start up companies. Recnetly, Michlin led the creation and capital raising of Yissum's new holding company in the biotech area -Integra that acts as VC to fund biotech projects of HU and Agrinnovation that funds and invests in start up in the Agritech area. Michlin serves as chairman of Integra and Agrin-novation who manage $20 million investments. Michlin also led Yissum to the signing of long term collaborations with Roche, P&G , Coca Cola and other multinational companies. Michlin currently serves as chairman of Qlight Nanotech (in strategic collaboration with Merck) and Avraham Pharma (PIIb MCI Product) and as board member of few of Yissum leading spin-o� companies in the biotech,


agriculture and other �elds. In May 2015 Michlin resigned from his role as co-chairman of the Israeli Tech Transfer Organization after 3 years in which he managed to increase substantially the activities and marketing of the ITTN. Before joining Yissum, Yaacov was involved in consulting to pharmaceutical, hi-tech and biomedical companies (including Teva, Bioline, CBI and Brainsway) in various technology commercialization deals, licensing agreements, capital raising, mergers and acquisitions and joint venture collaborations. Michlin holds a Bachelor of Law and Economics, cum laude, and a Master of Law degree, both from Bar-Ilan University, Israel, and a MBA, cum laude, from the Technion Israel Institute of technology.

Yossi Moldawsky | Co-Founder & Chairman | Explore Dream Discover Technological Incubator

Yossi Moldawsky is the Founder, Co-Owner and Active Chairman of Moldawsky High-Tech, Moldawsky Group's Technology investment Division (1999). Founder, Controlling shareholder & Active Chairman of Plus Ventures, the �rst multi-vehicle early-stage investment �rm (over 30 portfolio companies). Founder, Controlling shareholder & Active Chairman of the Explore.Dream.Discover, technology licensed incubator, located in Yokneam.

Explore is one of the most active and successful incubators in Israel – 31 new portfolio companies in the last 3 yearsDeep knowledge of the Technological incubators Program, its bene�ts and its challenges.


Joey T. Shabot focuses his practice on mergers and acquisitions, including corporate law, securities law matters relating to M&A, and �nancing.His experience includes advising on mergers, acquisitions, joint ventures, partnerships, private investments in public entities (PIPEs), securities o�erings, and corporate governance, in transactions involving companies across a variety of industries based throughout the world including the U.S., Israel, Europe, Canada, Mexico, the Bahamas, Cayman Islands and China. He has also represented borrowers in �nancing aspects of leveraged acquisitions, including negotiation, implementation and issues of credit facilities and debt

securities. Joey also has particular experience advising potential purchasers and sellers of distressed assets, and assisting bank groups and investors in workouts and restructurings, both in and out of bankruptcy.Tech Transfer/

AcademicInstitutions1 Candidatewill be elected

Technological Incubators


ServiceProviders



Joey T. Shabot focuses his practice on mergers and acquisitions, including corporate law, securities law matters relating to M&A, and �nancing.His experience includes advising on mergers, acquisitions, joint ventures, partnerships, private investments in public entities (PIPEs), securities o�erings, and corporate governance, in transactions involving companies across a variety of industries based throughout the world including the U.S., Israel, Europe, Canada, Mexico, the Bahamas, Cayman Islands and China. He has also represented borrowers in �nancing aspects of leveraged acquisitions, including negotiation, implementation and issues of credit facilities and debt


securities. Joey also has particular experience advising potential purchasers and sellers of distressed assets, and assisting bank groups and investors in workouts and restructurings, both in and out of bankruptcy.

Jonathan Eilat | The Investor | Founder & CEO

BA and MBA in Business Administration (Finance/Marketing) –The Interdisciplinary Center in Hertzlia - Graduated cum laudeWork Experience:2007 – Present:TheInvestor – Investor and Public Relations Firm – Founder and General Manager.TheInvestor is a leading investor and public �rm in Israel, provide a complete range of investor communications, public relations and consulting services.

Past and present clients (partial list): Teva, Phoenix, Israel Electric Corporation, Magic, Nova, RR Media, Victory, Mer Group, Tadiran Holdings, Verint, ORL, Mishorim, Skyline, Sun Team, Top Image, IceCure, BATM, Allium medical, Radvision, Issta, Clal Bio, Chiron Re�neries, Photomedex, Matrix, Ezchip, Scopus.

Partner at the High-Tech Analysis Course with Tel-Aviv Stock Exchange, IATI and Oppenheimer-Israel.

Omer Ben Zvi | Shibolet & Co | Partner

Omer Ben Zvi is a partner in Shibolet & Co Born: Jerusalem, 1964; Grew up: Kiryat Tivon, "Shnat Sherut"; IDF: tank commander.Law degree: Anglia University, Essex, UK; Israeli Bar: 1994.High-Tech M&A lawyer for 20 years, focused on Israeli technology and international VC/PE, with an extensive network in the US, China and Russia. Founded my own boutique tech law �rm in 2003, and merged it into Shibolet & Co. in 2014. Participated in the Knesset high-tech industry lobby.

Why? I believe in the Israeli Tech industry, that’s today's Zionism.Purpose: (A) To strengthen the IL Tech industry - I think it needs much more international exposure. (B) The Tech industry needs to act a social leader - we must expand it to additional sectors in theIsraeli society.

ServiceProviders



Yoram Tietz | Ernst & Young | Managing Partner

Yoram is the Managing Partner of EY Israel, and the Assurance MP and ABD for the Israeli practice. Before becoming the Managing Partner, Yoram was the head of the High Tech practice, the largest of its kind in Israel. Yoram has over 20 years experience in serving major clients, providing professional services to hundreds of startups and publicly traded high tech companies.

Yoram has helped many clients in a multitude of issues advising management and the growth and management of their business. He has helped Entrepreneurs and Start-Ups strategize, raise money and grow their businesses. He has also participated in many M&A’s and IPO’s on NASDAQ and the European and Tel Aviv Public Capital Markets.

Yoram has degrees in accounting and economics from Tel Aviv University.

ServiceProviders


Documents

IATI BOARD CANDIDATES Board Candidates...Bio-Medical group at Xerox PARC. Dr. Wolkin received a PhD in Materials Science, focusing on Nanotechnology and Photonics from the University